Article | March 8, 2022

8 New Elements Of The IVDR — And How To Change Your Approach

Source: Premier Research

By Nach Davé

Medical concept image Blood test GettyImages-1208340299

If you develop or manufacture in-vitro diagnostic products, you know the May 2022 roll-out date for the In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) is just around the corner. But what, exactly, does that mean?

Many of our sponsors have been approaching us with questions, such as:

  • What aspects of the IVDR apply to my business?
  • What types of data generation need to be in place?
  • Does any grace period apply, given the December progressive rollout update?
  • Who can I work with to ensure there are no gaps in my understanding of compliance?

The answers, tiny details that could make or break in vitro diagnostic (IVD) approval, lie buried within an extensive document. Fortunately, we at Premier have done the digging — so you don’t have to.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader